{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:08:09Z","timestamp":1790118489430,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.urology.2020.05.076","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T20:58:29Z","timestamp":1592945909000},"page":"153-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Treatment-related Outcomes for Patients With Atypical Peyronie's Disease Using Xiaflex Injections"],"prefix":"10.1016","volume":"143","author":[{"given":"Farouk M.","family":"El-Khatib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad M.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"Kopelevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Towe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faysal A.","family":"Yafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2020.05.076_bib0001","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/ajcp\/45.6.670","article-title":"Peyronie's disease","volume":"45","author":"Smith","year":"1966","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.urology.2020.05.076_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/282503","article-title":"A population-based study of peyronie's disease: prevalence and treatment patterns in the United States","volume":"2011","author":"Dibenedetti","year":"2011","journal-title":"Adv Urol"},{"key":"10.1016\/j.urology.2020.05.076_bib0003","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1743-6109.2012.02999.x","article-title":"Psychological impact of peyronie's disease: a review","volume":"10","author":"Nelson","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2020.05.076_bib0004","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1111\/j.1743-6109.2008.00883.x","article-title":"Impact of Peyronie's disease on sexual and psychosocial functioning: qualitative findings in patients and controls","volume":"5","author":"Rosen","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2020.05.076_bib0005","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.aju.2013.06.006","article-title":"The pathophysiology of Peyronie's disease","volume":"11","author":"El-Sakka","year":"2013","journal-title":"Arab J Urol"},{"key":"10.1016\/j.urology.2020.05.076_bib0006","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.sxmr.2016.07.004","article-title":"Review of management options for patients with atypical Peyronie's disease","volume":"5","author":"Yafi","year":"2017","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.urology.2020.05.076_bib0007","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5152\/tud.2018.87405","article-title":"Peyronie's disease surgery: surgical outcomes of 268 cases","volume":"44","author":"Kad\u0131o\u011flu","year":"2018","journal-title":"Turk J Urol"},{"key":"10.1016\/j.urology.2020.05.076_bib0008","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.esxm.2018.07.003","article-title":"Beyond curvature: prevalence and characteristics of penile volume-loss deformities in men with peyronie's disease","volume":"6","author":"Margolin","year":"2018","journal-title":"Sex Med"},{"key":"10.1016\/j.urology.2020.05.076_bib0009","article-title":"Management of Peyronie's disease with collagenase Clostridium histolyticum in the acute phase","author":"El-Khatib","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2020.05.076_bib0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jsm.12337","article-title":"Concordance between patient and physician assessment of the magnitude of Peyronie's disease curvature","volume":"11","author":"Matsushita","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2020.05.076_bib0011","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.juro.2013.01.090","article-title":"Bother and distress associated with Peyronie's disease: validation of the Peyronie's disease questionnaire","volume":"190","author":"Hellstrom","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.05.076_bib0012","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.urology.2017.05.029","article-title":"Factors associated with erectile dysfunction and the Peyronie's disease questionnaire in patients with Peyronie disease","volume":"107","author":"Serefoglu","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.05.076_bib0013","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo-controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.05.076_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2015.06.013","article-title":"Collagenase Clostridium histolyticum (Xiaflex) for the treatment of urethral stricture disease in a rat model of urethral fibrosis","volume":"86","author":"Sangkum","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.05.076_bib0015","series-title":"Presented at: 21st Annual Fall Meeting of SMSNA","article-title":"Positive results with collagenase Clostridium histolyticum treatment in two patients with ventral penile curvature due to Peyronie's disease [abstract 116]","author":"Milam","year":"2015"},{"key":"10.1016\/j.urology.2020.05.076_bib0016","series-title":"Presented at: 20th Annual Fall Meeting of SMSNA","article-title":"Ventral intralesional verapamil injections for Peyronie's disease: feasibility and safety [abstract]","author":"Berookhim","year":"2014"},{"key":"10.1016\/j.urology.2020.05.076_bib0017","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.juro.2015.06.096","article-title":"Intralesional injection of interferon-a2b improves penile curvature in men with Peyronie's disease independent of plaque location","volume":"194","author":"Stewart","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.05.076_bib0018","doi-asserted-by":"crossref","unstructured":"Cocci A, Di Maida F, Russo GI et al. How atypical penile curvature influence clinical outcomes in patients with Peyronie's disease receiving collagenase Clostridium histolyticum therapy?World J Mens HealthPublished online May 29, 2019. https:\/\/doi.org\/10.5534\/wjmh.190026","DOI":"10.5534\/wjmh.190026"},{"key":"10.1016\/j.urology.2020.05.076_bib0019","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jsm.12731","article-title":"Clinical safety and effectiveness of collagenase Clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study","volume":"12","author":"Levine","year":"2015","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2020.05.076_bib0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1756287218755020","article-title":"Intralesional collagenase Clostridium histolyticum in the management of Peyronie's disease: current best practice","volume":"10","author":"Cwikla","year":"2018","journal-title":"Ther Adv Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042952030724X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042952030724X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:08:15Z","timestamp":1758766095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042952030724X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":20,"alternative-id":["S009042952030724X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2020.05.076","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment-related Outcomes for Patients With Atypical Peyronie's Disease Using Xiaflex Injections","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2020.05.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}